Marino Gloria E, Weeraratna Ashani T
Department of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Department of Oncology, Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland.
Aging Cancer. 2020 Dec;1(1-4):19-29. doi: 10.1002/aac2.12013. Epub 2020 Oct 7.
People over 55 years old represent the majority of cancer patients and suffer from increased metastatic burden compared to the younger patient population. As the aging population increases globally, it is prudent to understand how the intrinsic aging process contributes to cancer progression. As we age, we incur aberrant changes in the extracellular matrix (ECM) of our organs, which contribute to numerous pathologies, including cancer. Notably, the lung, liver, and bone represent the most common sites of distal metastasis for all cancer types. In this review, we describe how age-dependent changes in the ECM of these organs influence cancer progression. Further, we outline how these alterations prime the premetastatic niche and why these may help explain the disparity in outcome for older cancer patients.
55岁以上的人群占癌症患者的大多数,与年轻患者群体相比,他们承受着更大的转移负担。随着全球老龄化人口的增加,了解内在衰老过程如何促进癌症进展是明智的。随着年龄的增长,我们器官的细胞外基质(ECM)会发生异常变化,这会导致包括癌症在内的多种病理状况。值得注意的是,肺、肝和骨是所有癌症类型最常见的远处转移部位。在本综述中,我们描述了这些器官的ECM中与年龄相关的变化如何影响癌症进展。此外,我们概述了这些改变如何引发前转移微环境,以及为什么这些可能有助于解释老年癌症患者预后的差异。